Filing Details

Accession Number:
0001209191-18-029966
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-14 17:50:30
Reporting Period:
2018-02-21
Accepted Time:
2018-05-14 17:50:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1516479 Insys Therapeutics Inc. INSY () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1467848 Brian Tambi C/O Insys Therapeutics, Inc.
1333 South Spectrum Blvd, Suite 100
Chandler AZ 85286
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-21 4,000 $0.00 4,000 No 4 A Direct
Common Stock Acquisiton 2018-05-10 33,654 $0.61 37,654 No 4 M Direct
Common Stock Acquisiton 2018-05-10 68,850 $1.62 106,504 No 4 M Direct
Common Stock Acquisiton 2018-05-10 60,000 $3.63 166,504 No 4 M Direct
Common Stock Disposition 2018-05-10 166,504 $6.41 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2018-02-21 4,000 $0.00 4,000 $0.00
Common Stock Stock Option (right to buy) Disposition 2018-05-10 33,654 $0.00 33,654 $0.61
Common Stock Stock Option (right to buy) Disposition 2018-05-10 68,850 $0.00 68,850 $1.62
Common Stock Stock Option (right to buy) Disposition 2018-05-10 60,000 $0.00 60,000 $3.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 D Direct
0 2020-02-21 No 4 M Direct
0 2021-03-28 No 4 M Direct
0 2023-05-13 No 4 M Direct
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.61 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  3. The restricted stock units ("RSUs") vested on the one year anniversary of the date of grant.
  4. The exercise price reflects a 3-for-2 forward stock split effected by the Issuer on March 28, 2014 and a 2-for-1 forward stock split effected by the Issuer on June 5, 2015.
  5. The option is fully vested and exercisable.